The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Sphingosine-1-Receptor Modulators Drugs Market Research Report 2025
Synopsis
Sphingosine-1-phosphate receptor 1 (S1P receptor 1 or S1P1), also known as endothelial differentiation gene 1 (EDG1) is a protein that in humans is encoded by the S1PR1 gene. S1PR1 is a G-protein-coupled receptor which binds the bioactive signaling molecule sphingosine 1-phosphate (S1P). S1PR1 belongs to a sphingosine-1-phosphate receptor subfamily comprising five members (S1PR1-5). S1PR1 was originally identified as an abundant transcript in endothelial cells and it has an important role in regulating endothelial cell cytoskeletal structure, migration, capillary-like network formation and vascular maturation. In addition, S1PR1 signaling is important in the regulation of lymphocyte maturation, migration and trafficking.
The global Sphingosine-1-Receptor Modulators Drugs market was valued at US$ 3983.6 million in 2023 and is anticipated to reach US$ 6572.4 million by 2030, witnessing a CAGR of 7.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Sphingosine-1-Receptor Modulators Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sphingosine-1-Receptor Modulators Drugs.
Report Scope
The Sphingosine-1-Receptor Modulators Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sphingosine-1-Receptor Modulators Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sphingosine-1-Receptor Modulators Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Arena Pharmaceuticals
Idorsia
Sun Pharma
Biocon
HEC Pharm Co. Limited
Segment by Type
Fingolimod
Siponimod
Ozanimod
Other
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sphingosine-1-Receptor Modulators Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sphingosine-1-Receptor Modulators Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Sphingosine-1-phosphate receptor 1 (S1P receptor 1 or S1P1), also known as endothelial differentiation gene 1 (EDG1) is a protein that in humans is encoded by the S1PR1 gene. S1PR1 is a G-protein-coupled receptor which binds the bioactive signaling molecule sphingosine 1-phosphate (S1P). S1PR1 belongs to a sphingosine-1-phosphate receptor subfamily comprising five members (S1PR1-5). S1PR1 was originally identified as an abundant transcript in endothelial cells and it has an important role in regulating endothelial cell cytoskeletal structure, migration, capillary-like network formation and vascular maturation. In addition, S1PR1 signaling is important in the regulation of lymphocyte maturation, migration and trafficking.
The global Sphingosine-1-Receptor Modulators Drugs market was valued at US$ 3983.6 million in 2023 and is anticipated to reach US$ 6572.4 million by 2030, witnessing a CAGR of 7.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Sphingosine-1-Receptor Modulators Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sphingosine-1-Receptor Modulators Drugs.
Report Scope
The Sphingosine-1-Receptor Modulators Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sphingosine-1-Receptor Modulators Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sphingosine-1-Receptor Modulators Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Arena Pharmaceuticals
Idorsia
Sun Pharma
Biocon
HEC Pharm Co. Limited
Segment by Type
Fingolimod
Siponimod
Ozanimod
Other
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sphingosine-1-Receptor Modulators Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sphingosine-1-Receptor Modulators Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Sphingosine-1-Receptor Modulators Drugs Market Overview
1.1 Product Overview and Scope of Sphingosine-1-Receptor Modulators Drugs
1.2 Sphingosine-1-Receptor Modulators Drugs Segment by Type
1.2.1 Global Sphingosine-1-Receptor Modulators Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Fingolimod
1.2.3 Siponimod
1.2.4 Ozanimod
1.2.5 Other
1.3 Sphingosine-1-Receptor Modulators Drugs Segment by Application
1.3.1 Global Sphingosine-1-Receptor Modulators Drugs Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Sphingosine-1-Receptor Modulators Drugs Market Size Estimates and Forecasts
1.4.1 Global Sphingosine-1-Receptor Modulators Drugs Revenue 2019-2030
1.4.2 Global Sphingosine-1-Receptor Modulators Drugs Sales 2019-2030
1.4.3 Global Sphingosine-1-Receptor Modulators Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Sphingosine-1-Receptor Modulators Drugs Market Competition by Manufacturers
2.1 Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Sphingosine-1-Receptor Modulators Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Sphingosine-1-Receptor Modulators Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sphingosine-1-Receptor Modulators Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sphingosine-1-Receptor Modulators Drugs, Product Type & Application
2.7 Sphingosine-1-Receptor Modulators Drugs Market Competitive Situation and Trends
2.7.1 Sphingosine-1-Receptor Modulators Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sphingosine-1-Receptor Modulators Drugs Players Market Share by Revenue
2.7.3 Global Sphingosine-1-Receptor Modulators Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sphingosine-1-Receptor Modulators Drugs Retrospective Market Scenario by Region
3.1 Global Sphingosine-1-Receptor Modulators Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Sphingosine-1-Receptor Modulators Drugs Global Sphingosine-1-Receptor Modulators Drugs Sales by Region: 2019-2030
3.2.1 Global Sphingosine-1-Receptor Modulators Drugs Sales by Region: 2019-2024
3.2.2 Global Sphingosine-1-Receptor Modulators Drugs Sales by Region: 2025-2030
3.3 Global Sphingosine-1-Receptor Modulators Drugs Global Sphingosine-1-Receptor Modulators Drugs Revenue by Region: 2019-2030
3.3.1 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Region: 2019-2024
3.3.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Region: 2025-2030
3.4 North America Sphingosine-1-Receptor Modulators Drugs Market Facts & Figures by Country
3.4.1 North America Sphingosine-1-Receptor Modulators Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Sphingosine-1-Receptor Modulators Drugs Sales by Country (2019-2030)
3.4.3 North America Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Sphingosine-1-Receptor Modulators Drugs Market Facts & Figures by Country
3.5.1 Europe Sphingosine-1-Receptor Modulators Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Sphingosine-1-Receptor Modulators Drugs Sales by Country (2019-2030)
3.5.3 Europe Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sphingosine-1-Receptor Modulators Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Sphingosine-1-Receptor Modulators Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Sphingosine-1-Receptor Modulators Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Sphingosine-1-Receptor Modulators Drugs Market Facts & Figures by Country
3.7.1 Latin America Sphingosine-1-Receptor Modulators Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Sphingosine-1-Receptor Modulators Drugs Sales by Country (2019-2030)
3.7.3 Latin America Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sphingosine-1-Receptor Modulators Drugs Sales by Type (2019-2030)
4.1.1 Global Sphingosine-1-Receptor Modulators Drugs Sales by Type (2019-2024)
4.1.2 Global Sphingosine-1-Receptor Modulators Drugs Sales by Type (2025-2030)
4.1.3 Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Type (2019-2030)
4.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Type (2019-2030)
4.2.1 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Type (2019-2024)
4.2.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Type (2025-2030)
4.2.3 Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Sphingosine-1-Receptor Modulators Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Sphingosine-1-Receptor Modulators Drugs Sales by Application (2019-2030)
5.1.1 Global Sphingosine-1-Receptor Modulators Drugs Sales by Application (2019-2024)
5.1.2 Global Sphingosine-1-Receptor Modulators Drugs Sales by Application (2025-2030)
5.1.3 Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Application (2019-2030)
5.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Application (2019-2030)
5.2.1 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Application (2019-2024)
5.2.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Application (2025-2030)
5.2.3 Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Sphingosine-1-Receptor Modulators Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Sphingosine-1-Receptor Modulators Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Sphingosine-1-Receptor Modulators Drugs Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Bristol-Myers Squibb
6.2.1 Bristol-Myers Squibb Corporation Information
6.2.2 Bristol-Myers Squibb Description and Business Overview
6.2.3 Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Product Portfolio
6.2.5 Bristol-Myers Squibb Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Arena Pharmaceuticals
6.4.1 Arena Pharmaceuticals Corporation Information
6.4.2 Arena Pharmaceuticals Description and Business Overview
6.4.3 Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Product Portfolio
6.4.5 Arena Pharmaceuticals Recent Developments/Updates
6.5 Idorsia
6.5.1 Idorsia Corporation Information
6.5.2 Idorsia Description and Business Overview
6.5.3 Idorsia Sphingosine-1-Receptor Modulators Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Idorsia Sphingosine-1-Receptor Modulators Drugs Product Portfolio
6.5.5 Idorsia Recent Developments/Updates
6.6 Sun Pharma
6.6.1 Sun Pharma Corporation Information
6.6.2 Sun Pharma Description and Business Overview
6.6.3 Sun Pharma Sphingosine-1-Receptor Modulators Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sun Pharma Sphingosine-1-Receptor Modulators Drugs Product Portfolio
6.6.5 Sun Pharma Recent Developments/Updates
6.7 Biocon
6.6.1 Biocon Corporation Information
6.6.2 Biocon Description and Business Overview
6.6.3 Biocon Sphingosine-1-Receptor Modulators Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biocon Sphingosine-1-Receptor Modulators Drugs Product Portfolio
6.7.5 Biocon Recent Developments/Updates
6.8 HEC Pharm Co. Limited
6.8.1 HEC Pharm Co. Limited Corporation Information
6.8.2 HEC Pharm Co. Limited Description and Business Overview
6.8.3 HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Product Portfolio
6.8.5 HEC Pharm Co. Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sphingosine-1-Receptor Modulators Drugs Industry Chain Analysis
7.2 Sphingosine-1-Receptor Modulators Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sphingosine-1-Receptor Modulators Drugs Production Mode & Process
7.4 Sphingosine-1-Receptor Modulators Drugs Sales and Marketing
7.4.1 Sphingosine-1-Receptor Modulators Drugs Sales Channels
7.4.2 Sphingosine-1-Receptor Modulators Drugs Distributors
7.5 Sphingosine-1-Receptor Modulators Drugs Customers
8 Sphingosine-1-Receptor Modulators Drugs Market Dynamics
8.1 Sphingosine-1-Receptor Modulators Drugs Industry Trends
8.2 Sphingosine-1-Receptor Modulators Drugs Market Drivers
8.3 Sphingosine-1-Receptor Modulators Drugs Market Challenges
8.4 Sphingosine-1-Receptor Modulators Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Sphingosine-1-Receptor Modulators Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Sphingosine-1-Receptor Modulators Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Sphingosine-1-Receptor Modulators Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Sphingosine-1-Receptor Modulators Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Sphingosine-1-Receptor Modulators Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Sphingosine-1-Receptor Modulators Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Sphingosine-1-Receptor Modulators Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Sphingosine-1-Receptor Modulators Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Sphingosine-1-Receptor Modulators Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Sphingosine-1-Receptor Modulators Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Sphingosine-1-Receptor Modulators Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Sphingosine-1-Receptor Modulators Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sphingosine-1-Receptor Modulators Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Sphingosine-1-Receptor Modulators Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Sphingosine-1-Receptor Modulators Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Sphingosine-1-Receptor Modulators Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Sphingosine-1-Receptor Modulators Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Sphingosine-1-Receptor Modulators Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Sphingosine-1-Receptor Modulators Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Sphingosine-1-Receptor Modulators Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Sphingosine-1-Receptor Modulators Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Sphingosine-1-Receptor Modulators Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Sphingosine-1-Receptor Modulators Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Sphingosine-1-Receptor Modulators Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Sphingosine-1-Receptor Modulators Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Sphingosine-1-Receptor Modulators Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Sphingosine-1-Receptor Modulators Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Sphingosine-1-Receptor Modulators Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Sphingosine-1-Receptor Modulators Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Sphingosine-1-Receptor Modulators Drugs Price (US$/Unit) by Type (2019-2024)
Table 59. Global Sphingosine-1-Receptor Modulators Drugs Price (US$/Unit) by Type (2025-2030)
Table 60. Global Sphingosine-1-Receptor Modulators Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Sphingosine-1-Receptor Modulators Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Sphingosine-1-Receptor Modulators Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Sphingosine-1-Receptor Modulators Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Sphingosine-1-Receptor Modulators Drugs Price (US$/Unit) by Application (2019-2024)
Table 69. Global Sphingosine-1-Receptor Modulators Drugs Price (US$/Unit) by Application (2025-2030)
Table 70. Novartis Corporation Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Novartis Sphingosine-1-Receptor Modulators Drugs Product
Table 74. Novartis Recent Developments/Updates
Table 75. Bristol-Myers Squibb Corporation Information
Table 76. Bristol-Myers Squibb Description and Business Overview
Table 77. Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Product
Table 79. Bristol-Myers Squibb Recent Developments/Updates
Table 80. Johnson & Johnson Corporation Information
Table 81. Johnson & Johnson Description and Business Overview
Table 82. Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Product
Table 84. Johnson & Johnson Recent Developments/Updates
Table 85. Arena Pharmaceuticals Corporation Information
Table 86. Arena Pharmaceuticals Description and Business Overview
Table 87. Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Product
Table 89. Arena Pharmaceuticals Recent Developments/Updates
Table 90. Idorsia Corporation Information
Table 91. Idorsia Description and Business Overview
Table 92. Idorsia Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Idorsia Sphingosine-1-Receptor Modulators Drugs Product
Table 94. Idorsia Recent Developments/Updates
Table 95. Sun Pharma Corporation Information
Table 96. Sun Pharma Description and Business Overview
Table 97. Sun Pharma Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Sun Pharma Sphingosine-1-Receptor Modulators Drugs Product
Table 99. Sun Pharma Recent Developments/Updates
Table 100. Biocon Corporation Information
Table 101. Biocon Description and Business Overview
Table 102. Biocon Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Biocon Sphingosine-1-Receptor Modulators Drugs Product
Table 104. Biocon Recent Developments/Updates
Table 105. HEC Pharm Co. Limited Corporation Information
Table 106. HEC Pharm Co. Limited Description and Business Overview
Table 107. HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Product
Table 109. HEC Pharm Co. Limited Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Sphingosine-1-Receptor Modulators Drugs Distributors List
Table 113. Sphingosine-1-Receptor Modulators Drugs Customers List
Table 114. Sphingosine-1-Receptor Modulators Drugs Market Trends
Table 115. Sphingosine-1-Receptor Modulators Drugs Market Drivers
Table 116. Sphingosine-1-Receptor Modulators Drugs Market Challenges
Table 117. Sphingosine-1-Receptor Modulators Drugs Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Sphingosine-1-Receptor Modulators Drugs
Figure 2. Global Sphingosine-1-Receptor Modulators Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Sphingosine-1-Receptor Modulators Drugs Market Share by Type in 2023 & 2030
Figure 4. Fingolimod Product Picture
Figure 5. Siponimod Product Picture
Figure 6. Ozanimod Product Picture
Figure 7. Other Product Picture
Figure 8. Global Sphingosine-1-Receptor Modulators Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Sphingosine-1-Receptor Modulators Drugs Market Share by Application in 2023 & 2030
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Other
Figure 13. Global Sphingosine-1-Receptor Modulators Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Sphingosine-1-Receptor Modulators Drugs Market Size (2019-2030) & (US$ Million)
Figure 15. Global Sphingosine-1-Receptor Modulators Drugs Sales (2019-2030) & (K Units)
Figure 16. Global Sphingosine-1-Receptor Modulators Drugs Average Price (US$/Unit) & (2019-2030)
Figure 17. Sphingosine-1-Receptor Modulators Drugs Report Years Considered
Figure 18. Sphingosine-1-Receptor Modulators Drugs Sales Share by Manufacturers in 2023
Figure 19. Global Sphingosine-1-Receptor Modulators Drugs Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Sphingosine-1-Receptor Modulators Drugs Players: Market Share by Revenue in 2023
Figure 21. Sphingosine-1-Receptor Modulators Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Sphingosine-1-Receptor Modulators Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Country (2019-2030)
Figure 24. North America Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Country (2019-2030)
Figure 25. United States Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Country (2019-2030)
Figure 28. Europe Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Country (2019-2030)
Figure 29. Germany Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Region (2019-2030)
Figure 36. China Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Country (2019-2030)
Figure 46. Latin America Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Sphingosine-1-Receptor Modulators Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Sphingosine-1-Receptor Modulators Drugs by Type (2019-2030)
Figure 56. Global Revenue Market Share of Sphingosine-1-Receptor Modulators Drugs by Type (2019-2030)
Figure 57. Global Sphingosine-1-Receptor Modulators Drugs Price (US$/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Sphingosine-1-Receptor Modulators Drugs by Application (2019-2030)
Figure 59. Global Revenue Market Share of Sphingosine-1-Receptor Modulators Drugs by Application (2019-2030)
Figure 60. Global Sphingosine-1-Receptor Modulators Drugs Price (US$/Unit) by Application (2019-2030)
Figure 61. Sphingosine-1-Receptor Modulators Drugs Value Chain
Figure 62. Sphingosine-1-Receptor Modulators Drugs Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
